Early detection of lung cancer via biointerference-free, target microRNA-triggered core–satellite nanocomposites

= 10) lung cancer patients. We, therefore, believe that this proposed strategy will have high clinical potential for sensitive quantification of miRNA markers in liquid biopsy samples and act as a complementary method for the early detection of lung cancer.